Erik Badings

Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure

Dirk J. Lok, Sjoukje I. Lok, Pieta W. Bruggink‐André de la Porte et al. · Clinical Research in Cardiology · 2012 · 214 citations · Full text

Medicine, Cardiology, Physiology +13

Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer–Alkmaar heart failure study

Pieta W.F. Bruggink‐André de la Porte, Dirk J. Lok, Dirk J. van Veldhuisen et al. · Heart · 2006 · 146 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Incremental Prognostic Power of Novel Biomarkers (Growth-Differentiation Factor-15, High-Sensitivity C-Reactive Protein, Galectin-3, and High-Sensitivity Troponin-T) in Patients With Advanced Chronic Heart Failure

Dirk J. Lok, IJsbrand T. Klip, Sjoukje I. Lok et al. · The American Journal of Cardiology · 2013 · 96 citations · Full text

Medicine, Cardiology, Clinical Cardiology +12

Obesity and Clomiphene Challenge Test as Predictors of Outcome of in vitro Fertilization and Intracytoplasmic Sperm Injection

Esther C.A.M. van Swieten, Loes van der Leeuw-Harmsen, Erik Badings et al. · Gynecologic and Obstetric Investigation · 2005 · 94 citations

Veterinary Medicine, Gynecology, Obstetrics +17

Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial

Erik Badings, Salem H.K. The, Jan‐Henk E. Dambrink et al. · EuroIntervention · 2013 · 75 citations

Medicine, Cardiology, Internal Medicine +17